Dr. Jennifer McVean, MD, stands at the forefront of pediatric endocrinology, dedicating her career to enhancing the lives of children and families affected by diabetes and endocrine disorders. Diagnosed with Type 1 diabetes at the age of 11, Dr. McVean brings a unique perspective to her practice, blending personal experience with professional expertise to offer compassionate and comprehensive care.
After earning her medical degree from the University of Minnesota Medical School, Dr. McVean completed her pediatric residency at the University of Colorado and a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. She is board-certified in both Pediatrics and Pediatric Endocrinology.
Throughout her career, Dr. McVean has held significant roles in esteemed healthcare institutions, including the University of Minnesota, Children’s Minnesota, and Gundersen Health System. Her work has been pivotal in advancing pediatric diabetes care through clinical practice, research, education, and medical innovation.
In her current role as Senior Director of Medical Affairs for Medtronic Diabetes, Dr. McVean focuses on developing and promoting advanced insulin delivery systems and continuous glucose monitoring technologies. Her contributions have been instrumental in improving outcomes for pediatric patients worldwide.
Dr. McVean’s research has significantly impacted the field. Notably, she co-authored a study titled “Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial,” published in JAMA. This research explores the potential of near-normal glucose levels initiated immediately after diagnosis to preserve pancreatic beta cell function by reducing glucotoxicity.
Beyond her clinical and research endeavors, Dr. McVean is deeply involved in diabetes advocacy and education. She has collaborated with organizations such as the Juvenile Diabetes Research Foundation (JDRF), the American Diabetes Association (ADA), and the Pediatric Endocrine Society. Her commitment extends to mentoring, community outreach, and supporting groundbreaking research aimed at improving diabetes awareness, prevention, and treatment.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
For more information about Dr. Jennifer McVean and her work, visit her profile at Hudson Physicians.